Navigation Links
Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Date:5/25/2011

NEW YORK, May 25, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

http://www.reportlinker.com/p0511069/Drug-Delivery-Devices-Market-Outlook-in-United-Kingdom-to-2017---Metered-Dose-Inhaler-Devices-Infusion-Systems-Central-Venous-Catheters-and-Needle-Free-Injections.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Summary

GlobalData's new report, "Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the four market categories.

- Global corporate-level profiles of key companies operating within the United Kingdom Drug Delivery Devices market.

- Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc., Sunovion, B. Braun Melsungen AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the United Kingdom Drug Delivery Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 11

2.1 What is This Report About? 11

3 Drug Delivery Devices In United Kingdom 12

3.1 Drug Delivery Devices, Market Segmentation 12

3.2 Drug Delivery Devices, United Kingdom, Overall Revenue ($m), 2003-2017 13

3.3 Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2010 15

3.4 Drug Delivery Devices Market, United Kingdom, Category Contribution (%), 2010 16

3.5 Drug Delivery Devices, United Kingdom, Category Volume (Units), 2003-2017 21

3.6 Drug Delivery Devices, United Kingdom, Company Share (2009-2010) 26

4 Central Venous Catheters In United Kingdom 28

4.1 Central Venous Catheters, Market Segmentation 28

4.2 Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2010 29

4.3 Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2010 30

4.4 Central Venous Catheters Overall Revenue (2003-2017) 31

4.5 Central Venous Catheters Overall Volume (2003-2017) 35

4.6 Central Venous Catheters Average Price (2003-2017) 39

4.7 Central Venous Catheters Distribution Share (2009-2010) 40

4.8 Central Venous Catheters, United Kingdom, Company Share (2009-2010) 41

5 Infusion Systems In United Kingdom 43

5.1 Infusion Systems, Market Segmentation 43

5.2 Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2010 44

5.3 Infusion Systems Market, United Kingdom, Segment Contribution (%), 2010 45

5.4 Infusion Systems Overall Revenue (2003-2017) 46

5.4.1 Syringe Pumps Revenue (2003-2010) 50

5.4.2 Ambulatory Infusion Pumps Revenue (2003-2010) 54

5.5 Infusion Systems Overall Volume (2003-2017) 58

5.5.1 Syringe Pumps Volume (2003-2010) 62

5.5.2 Ambulatory Infusion Pumps Volume (2003-2010) 65

5.6 Infusion Systems Average Price (2003-2017) 69

5.7 Infusion Systems Distribution Share (2009-2010) 70

5.8 Infusion Systems, United Kingdom, Company Share (2009-2010) 71

6 Metered Dose Inhaler Devices In United Kingdom 73

6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 73

6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 75

6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 77

6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 78

6.5 Metered Dose Inhaler Devices, United Kingdom, Company Share (2009-2010) 79

7 Needle Free Injections In United Kingdom 81

7.1 Needle Free Injections Overall Revenue (2003-2017) 81

7.2 Needle Free Injections Overall Volume (2003-2017) 83

7.3 Needle Free Injections Average Price (2003-2017) 85

7.4 Needle Free Injections Distribution Share (2009-2010) 86

7.5 Needle Free Injections, United Kingdom, Company Share (2009-2010) 87

8 Overview of Key Companies in United Kingdom Drug Delivery Devices Market 88

8.1 GlaxoSmithKline plc 88

8.1.1 Company Overview 88

8.1.2 Share in the United Kingdom Drug Delivery Devices Market 88

8.2 Boehringer Ingelheim GmbH 89

8.2.1 Company Overview 89

8.2.2 Share in the United Kingdom Drug Delivery Devices Market 89

8.3 AstraZeneca PLC 90

8.3.1 Company Overview 90

8.3.2 Share in the United Kingdom Drug Delivery Devices Market 90

8.4 Baxter International Inc. 91

8.4.1 Company Overview 91

8.4.2 Share in the United Kingdom Drug Delivery Devices Market 91

8.5 Sunovion 92

8.5.1 Share in the United Kingdom Drug Delivery Devices Market 92

8.6 B. Braun Melsungen AG 93

8.6.1 Company Overview 93

8.6.2 Share in the United Kingdom Drug Delivery Devices Market 93

8.7 CareFusion Corporation 94

8.7.1 Company Overview 94

8.8 Fresenius Kabi AG 94

8.8.1 Company Overview 94

8.9 Hospira, Inc. 94

8.9.1 Company Overview 94

8.10 Medtronic, Inc. 95

8.10.1 Company Overview 95

8.11 Smiths Medical 95

8.11.1 Company Overview 95

8.12 Terumo Corporation 95

8.12.1 Company Overview 95

8.13 Consort Medical plc 96

8.13.1 Company Overview 96

8.14 3M Health Care 96

8.14.1 Company Overview 96

8.15 Codman & Shurtleff, Inc. 96

8.15.1 Company Overview 96

8.16 JMS CO., LTD. 97

8.16.1 Company Overview 97

8.17 Teleflex Incorporated 97

8.17.1 Company Overview 97

8.18 Edwards Lifesciences Corporation 98

8.18.1 Company Overview 98

8.19 Cook Medical Incorporated 98

8.19.1 Company Overview 98

8.20 INJEX - Equidyne Systems 98

8.20.1 Company Overview 98

8.21 Bioject Medical Technologies Inc. 99

8.21.1 Company Overview 99

8.22 Antares Pharma, Inc. 99

8.22.1 Company Overview 99

9 Drug Delivery Devices Market Pipeline Products 100

10 Financial Deals Landscape 105

10.1 Acquisition 105

10.1.1 Runfold Medical Acquires Zimed 105

10.2 Partnerships 106

10.2.1 AorTech International Enters Into Technology License Agreement 106

11 Recent Developments 107

11.1 Strategy And Business Planning 107

11.1.1 Aug 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey 107

11.1.2 Jul 27, 2010: GE Healthcare Opens New $15 Million Life Sciences Manufacturing Center In Wales, UK 107

11.1.3 Jul 13, 2010: GE Healthcare Opens New Medical Technology Manufacturing Facility In Cardiff, UK 108

11.2 Legal and Regulatory 108

11.2.1 Jan 17, 2011: GlaxoSmithKline Announces Q4 2010 Legal Charge 108

12 Appendix 109

12.1 Definitions of Markets Covered in the Report 110

12.1.1 Drug Delivery Devices 110

12.2 Research Methodology 113

12.3 Secondary Research 113

12.4 Primary Research 114

12.5 Models 114

12.6 Forecasts 115

12.7 Expert Panels 115

12.8 GlobalData Consulting 115

12.9 Currency Conversion 115

12.10 Contact Us 116

12.11 Disclaimer 116

1.1 List of Tables

Table 1: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), 2003-2017 14

Table 2: Drug Delivery Devices Market, United Kingdom, Category Contribution (%), 2010 16

Table 3: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010 18

Table 4: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017 20

Table 5: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2003-2017 21

Table 6: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 23

Table 7: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 25

Table 8: Drug Delivery Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010 27

Table 9: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2010 30

Table 10: Central Venous Catheters, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 32

Table 11: Central Venous Catheters, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 34

Table 12: Central Venous Catheters, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 36

Table 13: Central Venous Catheters, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 38

Table 14: Central Venous Catheters, United Kingdom, Average Price ($), Historic, 2003-2010 39

Table 15: Central Venous Catheters, United Kingdom, Average Price ($), Forecast, 2010-2017 39

Table 16: Central Venous Catheters, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 40

Table 17: Central Venous Catheters, United Kingdom, Company Share by Revenue ($m), 2009-2010 42

Table 18: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2010 45

Table 19: Infusion Systems, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 47

Table 20: Infusion Systems, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 49

Table 21: Syringe Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51

Table 22: Syringe Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53

Table 23: Ambulatory Infusion Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55

Table 24: Ambulatory Infusion Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57

Table 25: Infusion Systems, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 59

Table 26: Infusion Systems, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 61

Table 27: Syringe Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 63

Table 28: Syringe Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64

Table 29: Ambulatory Infusion Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 66

Table 30: Ambulatory Infusion Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68

Table 31: Infusion Systems, United Kingdom, Average Price ($), Historic, 2003-2010 69

Table 32: Infusion Systems, United Kingdom, Average Price ($), Forecast, 2010-2017 69

Table 33: Infusion Systems, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 70

Table 34: Infusion Systems, United Kingdom, Company Share by Revenue ($m), 2009-2010 72

Table 35: Metered Dose Inhaler Devices, United Kingdom, Revenue ($m) Historic, 2003-2010 73

Table 36: Metered Dose Inhaler Devices, United Kingdom, Revenue ($m) Forecast, 2010-2017 74

Table 37: Metered Dose Inhaler Devices, United Kingdom, Volume (Units) Historic, 2003-2010 75

Table 38: Metered Dose Inhaler Devices, United Kingdom, Volume (Units) Forecast, 2010-2017 76

Table 39: Metered Dose Inhaler Devices, United Kingdom, Average Price ($), Historic, 2003-2010 77

Table 40: Metered Dose Inhaler Devices, United Kingdom, Average Price ($), Forecast, 2010-2017 77

Table 41: Metered Dose Inhaler Devices, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 78

Table 42: Metered Dose Inhaler Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010 80

Table 43: Needle Free Injections, United Kingdom, Revenue ($m) Historic, 2003-2010 81

Table 44: Needle Free Injections, United Kingdom, Revenue ($m) Forecast, 2010-2017 82

Table 45: Needle Free Injections, United Kingdom, Volume (Units) Historic, 2003-2010 83

Table 46: Needle Free Injections, United Kingdom, Volume (Units) Forecast, 2010-2017 84

Table 47: Needle Free Injections, United Kingdom, Average Price ($), Historic, 2003-2010 85

Table 48: Needle Free Injections, United Kingdom, Average Price ($), Forecast, 2010-2017 85

Table 49: Needle Free Injections, United Kingdom, Distribution Share by Revenue ($m), 2009-2010 86

Table 50: Needle Free Injections, United Kingdom, Company Share by Revenue ($m), 2009-2010 87

Table 51: Drug Delivery Devices Market Pipeline Products 100

Table 52: Runfold Medical Acquires Zimed 105

Table 53: AorTech International Enters Into Technology License Agreement 106

Table 54: USD to Local Currency, United Kingdom, Average Actual Rate 2003-2010 115

1.2 List of Figures

Figure 1: Drug Delivery Devices, Market Segmentation 12

Figure 2: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), 2003-2017 13

Figure 3: Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2010 15

Figure 4: Drug Delivery Devices Market, United Kingdom, Category Contribution (%), 2010 16

Figure 5: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010 17

Figure 6: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017 19

Figure 7: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2003-2017 21

Figure 8: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 22

Figure 9: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 24

Figure 10: Drug Delivery Devices, United Kingdom, Company Share (%), 2010 26

Figure 11: Central Venous Catheters, Market Segmentation 28

Figure 12: Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2010 29

Figure 13: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2010 30

Figure 14: Central Venous Catheters, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 31

Figure 15: Central Venous Catheters, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 33

Figure 16: Central Venous Catheters, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 35

Figure 17: Central Venous Catheters, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 37

Figure 18: Central Venous Catheters, United Kingdom, Company Share (%), 2010 41

Figure 19: Infusion Systems, Market Segmentation 43

Figure 20: Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2010 44

Figure 21: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2010 45

Figure 22: Infusion Systems, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010 46

Figure 23: Infusion Systems, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017 48

Figure 24: Syringe Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 50

Figure 25: Syringe Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 52

Figure 26: Ambulatory Infusion Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010 54

Figure 27: Ambulatory Infusion Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 56

Figure 28: Infusion Systems, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 58

Figure 29: Infusion Systems, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 60

Figure 30: Syringe Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 62

Figure 31: Syringe Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64

Figure 32: Ambulatory Infusion Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 65

Figure 33: Ambulatory Infusion Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 67

Figure 34: Infusion Systems, United Kingdom, Company Share (%), 2010 71

Figure 35: Metered Dose Inhaler Devices, United Kingdom, Revenue ($m) Historic, 2003-2010 73

Figure 36: Metered Dose Inhaler Devices, United Kingdom, Revenue ($m) Forecast, 2010-2017 74

Figure 37: Metered Dose Inhaler Devices, United Kingdom, Volume (Units) Historic, 2003-2010 75

Figure 38: Metered Dose Inhaler Devices, United Kingdom, Volume (Units) Forecast, 2010-2017 76

Figure 39: Metered Dose Inhaler Devices, United Kingdom, Company Share (%), 2010 79

Figure 40: Needle Free Injections, United Kingdom, Revenue ($m) Historic, 2003-2010 81

Figure 41: Needle Free Injections, United Kingdom, Revenue ($m) Forecast, 2010-2017 82

Figure 42: Needle Free Injections, United Kingdom, Volume (Units) Historic, 2003-2010 83

Figure 43: Needle Free Injections, United Kingdom, Volume (Units) Forecast, 2010-2017 84

Figure 44: Needle Free Injections, United Kingdom, Company Share (%), 2010 87

Figure 45: GlaxoSmithKline plc, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010 88

Figure 46: Boehringer Ingelheim GmbH, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010 89

Figure 47: AstraZeneca PLC, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010 90

Figure 48: Baxter International Inc., Company Share (%),United Kingdom Drug Delivery Devices Market, 2010 91

Figure 49: Sunovion, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010 92

Figure 50: B. Braun Melsungen AG, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010 93

Companies MentionedGlaxoSmithKline plc

Boehringer Ingelheim GmbH

AstraZeneca PLC

Baxter International Inc.

Sunovion

B. Braun Melsungen AG

CareFusion Corporation

Fresenius Kabi AG

Hospira, Inc.

Medtronic, Inc.

Smiths Medical

Terumo Corporation

Consort Medical plc

3M Health Care

Codman & Shurtleff, Inc.

JMS CO., LTD.

Teleflex Incorporated

Edwards Lifesciences Corporation

Cook Medical Incorporated

INJEX - Equidyne Systems

Bioject Medical Technologies Inc.

Antares Pharma, Inc.

To order this report:

Drug Delivery Technology Industry: Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Drug Delivery Technology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
2. Reportlinker Adds Chinese Pharmaceutical Regulatory Report 2011
3. Reportlinker Adds Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
4. Reportlinker Adds Triple Analysis: Colorectal Cancer, Lymphoma and Peptides
5. Reportlinker Adds Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer
6. Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies
7. Reportlinker Adds Triple Analysis: Colorectal Cancer, Lymphoma and Pancreatic Cancer
8. Reportlinker Adds United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017
9. Reportlinker Adds Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
10. Reportlinker Adds Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
11. Reportlinker Adds Pharmaceuticals Industry Report - Top 500 Pharmaceuticals Industry Report (Global)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... North Carolina , 12 februari 2016 ... Inc. (AAI/CML), een toonaangevende leverancier van productie ... en biotechnologische industrieën, kondigt vandaag een uitbreiding ... mogelijkheden op haar locatie in ... vraag heeft geleid tot meerdere recente investeringen. ...
(Date:2/12/2016)... 2016 --> ... Inflammation Global Clinical Trials Review, H2, 2015 provides ... clinical trials landscape along with top level data ... (G7 & E7), Trial Status, Trial Phase, Sponsor ... companies involved and enlists all trials (Trial title, ...
(Date:2/11/2016)... 2016 Stem cells are primitive cells found ... and the capacity to differentiate into mature cell types ... the first mouse embryonic stem cells were derived from ... that the first culturing of embryonic stem cells from ... produced until 2006 As a result of these discoveries, ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... According to an ... beginning to account for a significant portion of hernia repairs throughout the United States. ... Beverly Hills Hernia Center notes that this trend has not only been expected, but ...
(Date:2/12/2016)... ... ... CDRH Enforcement Trends: , Back to the Future , Feb. 25, 2016 — 11:00 a.m. ... “Those who don’t learn from history are doomed to repeat it.” , An analysis of ... year. But that takes time. , Take a close look at the warning letters ...
(Date:2/12/2016)... ... 2016 , ... T.E.N., a technology and information security executive ... Awards 2016. Finalists and winners of the ISE® Awards for both Executive and ... Gala on March 15, 2016 at the Westin Peachtree Plaza, Atlanta. , ...
(Date:2/12/2016)... ... , ... AssureVest Insurance Group, a locally owned insurance firm with offices serving ... funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and 3rd grade ... a low-income area and has more than 60 2nd and 3rd graders with learning ...
(Date:2/12/2016)... San Ramon, CA (PRWEB) , ... February 12, 2016 , ... ... tissue donation in northern California and Nevada, announced a partnership with San Ramon Regional ... be transferred to the hospital’s facilities as a way to accommodate a more certain ...
Breaking Medicine News(10 mins):